Bligh James - Insider Non-Derivative Transactions at CONDUIT PHARMACEUTICALS INC. (CDT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 11, 2024, Bligh James's relationship to CONDUIT PHARMACEUTICALS INC. (CDT) is Director,Officer (Interim CFO), and currently has 37,272 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CDT insiders.

Data Source: SEC.
Bligh James - Insider Non-Derivative Transactions of CDT Common Stock
Bligh James - Insider Non-Derivative Transactions at CDT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 12, 2024 Acquisition -- (Common Stock) 37272 0 37272